These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18820805)

  • 41. [The chronic complications of diabetes].
    Sanmartín EF
    Rev Enferm; 1990 May; 13(141 Suppl):14-8. PubMed ID: 2359931
    [No Abstract]   [Full Text] [Related]  

  • 42. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.
    Groop PH; Forsblom C; Thomas MC
    Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):100-10. PubMed ID: 16929378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease.
    Williams ME
    Curr Diab Rep; 2004 Dec; 4(6):441-6. PubMed ID: 15539009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
    Takeuchi M; Takino J; Yamagishi S
    Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced glycation end products and vascular structure and function.
    Soldatos G; Cooper ME
    Curr Hypertens Rep; 2006 Dec; 8(6):472-8. PubMed ID: 17087858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
    Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
    Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diabetic complication: definition and classification].
    Nishizawa Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():3-8. PubMed ID: 2033818
    [No Abstract]   [Full Text] [Related]  

  • 49. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets.
    Sourris KC; Forbes JM
    Curr Drug Targets; 2009 Jan; 10(1):42-50. PubMed ID: 19149535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Late complications of diabetes mellitus type II (non-insulin- dependent)].
    Czech A
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():23-8. PubMed ID: 8516200
    [No Abstract]   [Full Text] [Related]  

  • 51. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microvascular complications of diabetes.
    He Z; King GL
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):215-38, xi-xii. PubMed ID: 15053904
    [No Abstract]   [Full Text] [Related]  

  • 53. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure.
    Aronson D
    Med Hypotheses; 2002 Sep; 59(3):297-301. PubMed ID: 12208156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes and advanced glycation endproducts.
    Vlassara H; Palace MR
    J Intern Med; 2002 Feb; 251(2):87-101. PubMed ID: 11905595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary natural products as a potential inhibitor towards advanced glycation end products and hyperglycemic complications: A phytotherapy approaches.
    M V; Wang K
    Biomed Pharmacother; 2021 Dec; 144():112336. PubMed ID: 34678719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hypertension and abnormal lipid metabolism].
    Nishimura H
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():258-62. PubMed ID: 23156404
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of AGEs in diabetic nephropathy.
    Fukami K; Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2008; 14(10):946-52. PubMed ID: 18473844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.
    Stitt AW; Frizzell N; Thorpe SR
    Curr Pharm Des; 2004; 10(27):3349-60. PubMed ID: 15544520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced glycation endproducts and diabetic nephropathy.
    Makita Z; Yanagisawa K; Kuwajima S; Yoshioka N; Atsumi T; Hasunuma Y; Koike T
    J Diabetes Complications; 1995; 9(4):265-8. PubMed ID: 8573743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.